The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
PASSAGE DES LIONS 6, CASE POSTALE 5653, 1211 GENEVE 11, SWITZERLAND
Tel:
Work +41 22 319 22 00
Fax:
Fax +41 22 319 22 01
Email:
Web:
www.mangeat.ch

Joël Chevallaz

Tel:
Work +41 22 319 22 00
Email:
Web:
www.mangeat.ch
Mangeat Attorneys at Law LLC

Work Department

Real Estate, Corporate Law, Consultation, Restructuring and Insolvency.

Position

Founder and Partner at MANGEAT

Career

Since 2016 Partner, MANGEAT, Geneva

2009 - 2015 Partner, Eversheds Ltd, Geneva

2003 - 2008 Partner, MCP Avocats, Geneva

1997 - 2003 Trainee at Briner & Brunisholz, Geneva

Languages

French, English

Member

Member of the Geneva Bar Association and of the Geneva Business Law Association.

Education

Master of Laws, University of Geneva, Switzerland.


Switzerland

Commercial, corporate and M&A

Within: Commercial, corporate and M&A

Mangeat Attorneys at Law LLC is recommended for having 'in-depth knowledge of commercial and corporate matters, combined with a thorough understanding of business implications and technological development'. M&A, corporate governance matters, reorganisations, compliance, commercial contracts and shareholder agreements form the bulk of its workload, while the banking, real estate and healthcare industries are sector strengths. The 'thorough and innovative' Fabien Aepli heads the practice, which also includes Joël Chevallaz and senior associate Nurith Cohen.

[back to top]

Real estate and construction

Within: Real estate and construction

Handling transactions, finance matters, environmental issues and development projects, the real estate team at Mangeat Attorneys at Law LLC assists developers, real estate companies, investors, architects and private clients located in Switzerland and France. Joël Chevallaz settled a contractual dispute and payment claims against a contractor for client Heka Constructeur d'Emotions, while Pierre Rüttimann advises Realswiss on the development of a residential portfolio in Switzerland, involving the creation and stock-exchange listing of a $100m real estate investment fund.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Advises Ashcroft on the Acquisition of RĂĽeger Holding

    Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based RĂĽeger Holding SA (RĂĽeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc RĂĽeger.
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from ElĂ©t

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.